SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-24-005002
Filing Date
2024-01-19
Accepted
2024-01-19 19:41:08
Documents
2
Period of Report
2024-01-18

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 4040
2 POWER OF ATTORNEY ea191908ex24_cadrenal.htm EX-24 6613
  Complete submission text file 0001213900-24-005002.txt   12101
Mailing Address C/O ARENA PHARMACEUTICALS, INC. 6154 NANCY RIDGE DRIVE SAN DIEGO CA 92121
Business Address
Lisicki Robert (Reporting) CIK: 0001779614 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41596 | Film No.: 24546836

Mailing Address 822 A1A NORTH SUITE 300 PONTE VEDRA FL 32082
Business Address 822 A1A NORTH SUITE 300 PONTE VEDRA FL 32082 904-300-0701
Cadrenal Therapeutics, Inc. (Issuer) CIK: 0001937993 (see all company filings)

IRS No.: 880860746 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)